ESC 365 - Which factors recorded during routine care predict treatment discontinuation of novel oral anticoagulants in patients with non-valvular atrial fibrillation?

EHRA Premium Access

Which factors recorded during routine care predict treatment discontinuation of novel oral anticoagulants in patients with non-valvular atrial fibrillation?

Session: Poster session 2 - Atrial Fibrillation - Clinical and epidemiological aspects

Topic: Clinical and epidemiological aspects (Atrial Fibrillation)

Speaker: Doctor C. Lefevre (Rueil-Malmaison, FR)

Event: EHRA EUROPACE - CARDIOSTIM 2017

Congress Presentation

Add to my library

About the speaker

Doctor Cinira Lefevre

Bristol-Myers Squibb, Rueil-Malmaison (France)

0 follower

23 more presentations in this session

Rhythm versus rate control in patients with atrial fibrillation combined with left ventricular systolic dysfunction: a meta-analysis

Speaker: Doctor J. Ahn (Pusan, KR)

Experience using interventional epicardial left atrial appendage ligation

Speaker: Doctor K. Nentwich (Bad Neustadt an der Saale, DE)

Optimal dose of dabigatran for the prevention of thromboembolism with minimal bleeding risk in patients with atrial fibrillation: from asian perspectives

Speaker: Associate Professor K. Lee (Gwangju, KR)

Modified application of SAME-TTR score in Asian patients with atrial fibrillation for choice of oral anticoagulants

Speaker: Associate Professor K. Lee (Gwangju, KR)

Association between the epicardial adipose tissue and coronary artery vasospasm during pulmonary vein isolation

Speaker: Doctor K. Minami (Utsunomiya, JP)

Access the full session

Poster session 2 - Atrial Fibrillation - Clinical and epidemiological aspects

Speakers: Doctor C. Lefevre, Doctor J. Ahn, Doctor K. Nentwich, Associate Professor K. Lee, Associate Professor K. Lee...

About the event

EHRA EUROPACE - CARDIOSTIM 2017

18 June - 21 June 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources